Skip to content
10-Q

Quarterly Report

F-STAR THERAPEUTICS, INC.

0000950170-22-024526

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2022 · Sep 30, 2022 21.86M sh
Shares Diluted Q3 2022 · Sep 30, 2022 21.51M sh
Shares Diluted Q3 2022 · Sep 30, 2021 20.62M sh
Shares Diluted Q3 2022 · Sep 30, 2021 15.3M sh
Shares Outstanding Q3 2022 · Sep 30, 2022 21.98M sh
Capex Q3 2022 · Sep 30, 2022 $282K
Capex Q3 2022 · Sep 30, 2021 $658K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$44.7M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$34.05M
Long Term Debt Q3 2022 · Sep 30, 2022 $8.53M
Long Term Debt Q3 2022 · Dec 31, 2021 $9.61M
Short Term Debt Q3 2022 · Sep 30, 2022 $1.32M
Short Term Debt Q3 2022 · Dec 31, 2021 $0
Cash And Equivalents Q3 2022 · Sep 30, 2022 $35.57M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $78.55M
Stockholders Equity Q3 2022 · Sep 30, 2022 $56.94M
Stockholders Equity Q3 2022 · Jun 30, 2022 $71.64M
Stockholders Equity Q3 2022 · Dec 31, 2021 $96.86M
Stockholders Equity Q3 2022 · Sep 30, 2021 $90.08M
Stockholders Equity Q3 2022 · Jun 30, 2021 $99.24M
Stockholders Equity Q3 2022 · Dec 31, 2020 $42.99M
Current Liabilities Q3 2022 · Sep 30, 2022 $14.68M
Current Liabilities Q3 2022 · Dec 31, 2021 $12.14M
Total Liabilities Q3 2022 · Sep 30, 2022 $26.78M
Total Liabilities Q3 2022 · Dec 31, 2021 $26.16M
Current Assets Q3 2022 · Sep 30, 2022 $49.61M
Current Assets Q3 2022 · Dec 31, 2021 $84.74M
Total Assets Q3 2022 · Sep 30, 2022 $83.72M
Total Assets Q3 2022 · Dec 31, 2021 $123.02M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.84
Eps Diluted Q3 2022 · Sep 30, 2022 −$2.30
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.52
Eps Diluted Q3 2022 · Sep 30, 2021 −$2.35
Eps Basic Q3 2022 · Sep 30, 2022 −$0.84
Eps Basic Q3 2022 · Sep 30, 2022 −$2.30
Eps Basic Q3 2022 · Sep 30, 2021 −$0.52
Eps Basic Q3 2022 · Sep 30, 2021 −$2.35
Sga Expense Q3 2022 · Sep 30, 2022 $5.16M
Sga Expense Q3 2022 · Sep 30, 2022 $18.32M
Sga Expense Q3 2022 · Sep 30, 2021 $5.24M
Sga Expense Q3 2022 · Sep 30, 2021 $18.17M
Rd Expense Q3 2022 · Sep 30, 2022 $9.67M
Rd Expense Q3 2022 · Sep 30, 2022 $26.43M
Rd Expense Q3 2022 · Sep 30, 2021 $5.11M
Rd Expense Q3 2022 · Sep 30, 2021 $20.54M
Net Income Q3 2022 · Sep 30, 2022 −$18.41M
Net Income Q3 2022 · Sep 30, 2022 −$49.49M
Net Income Q3 2022 · Sep 30, 2021 −$10.79M
Net Income Q3 2022 · Sep 30, 2021 −$36.02M
Operating Income Q3 2022 · Sep 30, 2022 −$13.71M
Operating Income Q3 2022 · Sep 30, 2022 −$41.08M
Operating Income Q3 2022 · Sep 30, 2021 −$9.6M
Operating Income Q3 2022 · Sep 30, 2021 −$35.04M
Revenue Q3 2022 · Sep 30, 2022 $1.13M
Revenue Q3 2022 · Sep 30, 2022 $3.68M
Revenue Q3 2022 · Sep 30, 2021 $751K
Revenue Q3 2022 · Sep 30, 2021 $3.67M